Mobilise-D: Extension Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNewcastle-upon-Tyne Hospitals NHS Trust
About this trial
The goal of this observational study is to investigate the ability of a mobility monitor to measure and predict outcomes in Parkinson's disease (PD). It is an extension of a previous study (the Mobilise-D Clinical Validation Study) and consists of an additional follow-up visit for PD participants and the recruitment of age matched control participants. The data will inform researchers about PD disease progression and normal changes in mobility associated with aging.
Eligibility criteria
Qualifiers
Aged 50 years or over
Able to walk 4 meters independently without walking aids
Anticipated availability for 12 months.
Ability to consent and comply with any study specific procedures.
Disqualifiers
Occurrence of any of the following within 3 months prior to informed consent: myocardial infarction, hospitalization for unstable angina, stroke, coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), implantation of a cardiac resynchronization therapy device (CRTD), active treatment for cancer or other malignant disease, uncontrolled congestive heart disease (NYHA class >3), acute psychosis or major psychiatric disorders or continued substance abuse, other neurological or orthopaedic impairment that significantly impacts on gait
Patients with a clinical diagnosis of PD, COPD, proximal hip fracture or MS
History of dementia/significant cognitive impairment, or movement disorder (including essential tremor)
Participant in the Mobilise-D Clinical Validation Study (CVS) PD Cohort - see below.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
651 Participants
are grouped into 2 trial groupsSponsors and collaborators
Newcastle-upon-Tyne Hospitals NHS Trust
Lead sponsor
KU Leuven
Collaborator
University of Kiel
Collaborator
University Hospital Erlangen
Collaborator
Tel-Aviv Sourasky Medical Center
Collaborator
University College Dublin
Collaborator
Source ClinicalTrials.gov